Promoting collaborations to improve birth defects surveillance, research, and prevention: A joint editorial from the National Birth Defects Prevention Network and the Organization of Teratology Information Specialists

Affiliations

¹ Utah Department of Health, Bureau of Maternal and Child Health, Mother To Baby Utah, Salt Lake City, Utah, USA.
² South Carolina Department of Health and Environmental Control, Birth Defects Program, Columbia, South Carolina, USA.
³ Utah Department of Health, Bureau of Children with Special Health Care Needs, Utah Birth Defect Network, Salt Lake City, Utah, USA.
⁴ Department of Pediatrics and Wertheim School of Public Health, University of California San Diego, La Jolla, California, USA.
⁵ Arizona Department of Health Services, Bureau of Public Health Statistics, Arizona Birth Defects Monitoring Program, Phoenix, Arizona, USA.
⁶ Section of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
⁷ College of Public Health, University of South Florida, Tampa, Florida, USA.

Editorial

Alfred N Romeo et al. Birth Defects Res. 2021.

. 2021 Jan 15;113(2):117-122.

doi: 10.1002/bdr2.1852. Epub 2020 Dec 14.

¹ Utah Department of Health, Bureau of Maternal and Child Health, Mother To Baby Utah, Salt Lake City, Utah, USA.
² South Carolina Department of Health and Environmental Control, Birth Defects Program, Columbia, South Carolina, USA.
³ Utah Department of Health, Bureau of Children with Special Health Care Needs, Utah Birth Defect Network, Salt Lake City, Utah, USA.
⁴ Department of Pediatrics and Wertheim School of Public Health, University of California San Diego, La Jolla, California, USA.
⁵ Arizona Department of Health Services, Bureau of Public Health Statistics, Arizona Birth Defects Monitoring Program, Phoenix, Arizona, USA.
⁶ Section of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
⁷ College of Public Health, University of South Florida, Tampa, Florida, USA.

No abstract available

References

1. Campbell, S. C., Kast, T. T., Kamyar, M., Robertson, J., & Sherwin, C. M. (2016). Calls to a teratogen information service regarding potential exposures in pregnancy and breastfeeding. BMC Pharmacology and Toxicology, 17, 33. https://doi.org/10.1186/s40360-016-0076-7
1. Chambers, C. D., Braddock, S. R., Briggs, G. G., Einarson, A., Johnson, Y. R., Miller, R. K., … Jones, K. L. (2001). Postmarketing surveillance for human teratogenicity: A model approach. Teratology, 64, 252-261. https://doi.org/10.1002/tera.1071
1. Chambers, C. D., Johnson, D., Xu, R., Lou, Y., Louik, C., Mitchell, A. A., … the OTIS Collaborative Research Group. (2013). Risks and safety of pandemic h1n1 influenza vaccine in pregnancy: Birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants. Vaccine, 31, 5026-5032. https://doi.org/10.1016/j.vaccine.2013.08.097
1. Clementi, M., & Ornoy, A. (2004). NATO advanced research workshop on “drugs in pregnancy: Consensus conference on teratogen information services”, Prague, 16-18 April 2004. Reproductive Toxicology, 19, 239-260.
1. Conover, E. A., & Polifka, J. E. (2011). The art and science of teratogen risk communication. American Journal of Medical Genetics Part C (Seminars in Medical Genetics), 157, 227-223. https://doi.org/10.1002/ajmg.c.30308